Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009 We analyzed clinical and molecular features from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results